Home4503 • TYO
add
Astellas Pharma Inc
Nakaraang pagsara
¥1,385.00
Sakop ng araw
¥1,384.00 - ¥1,404.00
Sakop ng taon
¥1,243.50 - ¥1,835.00
Market cap
2.54T JPY
Average na Volume
4.78M
P/E ratio
49.65
Dividend yield
5.28%
Primary exchange
TYO
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 459.29B | 10.78% |
Gastos sa pagpapatakbo | 297.34B | 5.59% |
Net na kita | 74.90B | 325.06% |
Net profit margin | 16.31 | 303.11% |
Kita sa bawat share | — | — |
EBITDA | 132.78B | 22.48% |
Aktuwal na % ng binabayarang buwis | -23.68% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 188.37B | -43.88% |
Kabuuang asset | 3.34T | -6.44% |
Kabuuang sagutin | 1.83T | -7.46% |
Kabuuang equity | 1.51T | — |
Natitirang share | 1.79B | — |
Presyo para makapag-book | 1.64 | — |
Return on assets | 6.26% | — |
Return on capital | 8.76% | — |
Cash Flow
Net change in cash
| (JPY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 74.90B | 325.06% |
Cash mula sa mga operasyon | 101.08B | 40.42% |
Cash mula sa pag-invest | -2.96B | 86.62% |
Cash mula sa financing | -90.81B | -393.61% |
Net change in cash | 8.51B | -89.59% |
Malayang cash flow | 56.01B | 1.63% |
Tungkol
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Itinatag
Abr 1, 2005
Headquarters
Website
Mga Empleyado
13,643
